Tokyo, Jan. 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060273) titled 'Molecular subtyping of autism spectrum disorder using whole-cortex omics analysis' on Jan. 6.
Study Type:
Observational
Primary Sponsor:
Institute - National Center of Neurology and Psychiatry
Condition:
Condition - Autism spectrum disorder (ASD)
Classification by malignancy - Others
Genomic information - YES
Objective:
Narrative objectives1 - To analyze anonymized existing multi-omics data (bulk and single-cell transcriptomics, ATAC-seq, histone acetylation, DNA methylation, miRNA, etc.) from 11 cortical regions in ASD and control subjects stored in the PsychENCODE/NRGR database, and to characterize molecular sub...